Showing results (1-10 of 51) with videos related to
Sort By:
Pageof 6
Glycoconjugate Journal|December 1, 1994
Labelling of high molecular weight hyaluronan with 125I-tyrosine: studies in vitro and in vivo in the ratS Gustafson, T Björkman, J E WestlinAnticancer Research|May 6, 1998
[111In-DTPA-D-Phe1]-octreotide scintigraphy in patients with hormone-refractory prostatic adenocarcinoma can predict therapy outcome with octreotide treatment: a pilot studyK M Kälkner, S Nilsson, J E WestlinAnticancer Research|May 16, 2000
89Strontium in the management of painful sceletal metastasesK M Kälkner, J E Westlin, P StrangInternational Journal of Radiation Oncology, Biology, Physics|March 8, 2000
Radiation doses to the cell nucleus in single cells and cells in micrometastases in targeted therapy with (131)I labeled ligands or antibodiesT Hartman, H Lundqvist, J E Westlin, et al.The Prostate|January 1, 1994
Estramustine potentiates the radiation effect in human prostate tumor transplant in nude miceS Eklöv, J E Westlin, G Rikner, et al.Cancer Research|December 1, 1995
Labeling of polypeptides with technetium-99m using a dextran spacerA Holmberg, M Marquez, J E Westlin, et al.Pediatric Research|March 1, 1997
The angiogenesis inhibitor TNP-470 reduces the growth rate of human neuroblastoma in nude ratsE Wassberg, S Påhlman, J E Westlin, et al.International Journal of Colorectal Disease|April 1, 1994
Adjuvant intraperitoneal 5-fluorouracil and intravenous leucovorin after colorectal cancer surgery: a randomized phase II placebo-controlled studyW Graf, J E Westlin, L Påhlman, et al.Cancer Research|August 15, 1988
Expression of an estramustine-binding associated protein in human lung cancer cell linesJ Bergh, P Björk, J E Westlin, et al.Acta Oncologica (Stockholm, Sweden)|January 1, 1993
Distribution and elimination of the somatostatin analogue (111In-DTPA-D-Phe1)-Octreotide (OctreoScan111)H Arnberg, J E Westlin, S Husin, et al.Pageof 6